author-photo

Xavier Tekpli

Oslo University Hospital

18

Papers

180

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Efficient gene expression signature for a breast cancer immuno-subtype.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (2)
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.

2021 Genome Medicine
Show All
- Source
- Cite
- Save
Citations (2)
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer

2020 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (2)
Crosstalk between microRNA expression and DNA methylation drive the hormone-dependent phenotype of breast cancer

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer.

2020 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (19)
Spatial Transcriptomics Inferred from Pathology Whole-Slide Images Links Tumor Heterogeneity to Survival in Breast and Lung Cancer

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment

2019 Nature Communications
Show All
- Source
- Cite
- Save
Citations (40)
Serum levels of inflammation‐related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers

2019 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Subtype-Specific Transcriptional Regulators in Breast Tumors Subjected to Genetic and Epigenetic Alterations

2019 Bioinformatics
Show All
- Source
- Cite
- Save
Citations (0)
Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab

2018 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (11)